Cardiac Pharmacology Effects on ECG Flashcards
7 cards from real CET practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Cardiac Pharmacology Effects on ECG flashcards as text
Amiodarone is known to prolong which ECG interval, increasing the risk of Torsades de Pointes?
Answer: QT interval
Amiodarone prolongs the QT interval by blocking potassium channels, which can precipitate Torsades de Pointes in susceptible patients.
A patient receiving IV adenosine for SVT shows a brief pause on the ECG strip. What does this pause represent?
Answer: Transient AV block
Adenosine transiently blocks AV conduction, producing a brief AV block that terminates re-entrant SVT and appears as a pause on the ECG.
Which beta-blocker ECG effect helps differentiate it from calcium channel blocker toxicity on the ECG?
Answer: Bradycardia with narrow QRS vs. bradycardia with wide QRS
Beta-blocker toxicity typically causes bradycardia with a narrow QRS, while calcium channel blocker toxicity may cause bradycardia with a wide QRS and conduction abnormalities.
Sotalol combines beta-blocking and Class III antiarrhythmic properties. Which ECG change is most expected?
Answer: Prolonged QT interval
Sotalol's Class III action blocks potassium channels, prolonging repolarization and the QT interval.
A patient on procainamide develops a wide-complex tachycardia on ECG. What drug toxicity phenomenon is most likely?
Answer: Proarrhythmia with widened QRS
Procainamide toxicity causes QRS widening due to sodium channel blockade, which can lead to proarrhythmic ventricular tachycardia.
Which ECG finding in a digitalis-toxic patient most urgently requires physician notification?
Answer: Bidirectional ventricular tachycardia
Bidirectional ventricular tachycardia is a hallmark of severe digitalis toxicity and is a life-threatening emergency requiring immediate intervention.
Flecainide, a Class IC drug, primarily affects the ECG by:
Answer: Widening the QRS complex significantly
Flecainide blocks fast sodium channels, markedly slowing intraventricular conduction and widening the QRS complex.